Centre for Research Excellence in Cervical Cancer Control (C4)

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1135172

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Cervical cancer remains common globally despite over 50 years of Pap testing. Australia led the world in HPV vaccination and in 2017 will be the first to deliver a national screening program based on HPV testing. Our CRE, led by cervical cancer prevention experts at CCNSW,VCS, and Kirby, will marry cross-disciplinary research and evaluation of HPV vaccination and screening to provide solid evidence about these new approaches with a view to ultimately reducing the global burden of this cancer.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2022

Funding Scheme: Centres of Research Excellence

Funding Amount: $2,486,383.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Preventive Medicine

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cervical cancer | cervical screening | human papillomavirus (HPV) | screening | vaccination

Related Links